New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:23 EDTSNSS, DNDNSunesis appoints Joseph DePinto as Chief Commercial Officer
Sunesis Pharmaceuticals (SNSS) announced the appointment of Joseph DePinto to the newly created position of executive vice president and Chief Commercial Officer. Prior to joining Sunesis, DePinto was Executive Vice President, Global Commercial Operations at Dendreon (DNDN).
News For SNSS;DNDN From The Last 14 Days
Check below for free stories on SNSS;DNDN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
13:51 EDTSNSSSunesis volatility elevated into data from trial
Sunesis overall option implied volatility of 298 is above its 26-week average of 156 according to Track Data, suggesting large price movement ahead of the upcoming release of data from a trial of its Qinprezo drug that is expected in the coming weeks.
09:41 EDTSNSSCitadel Advisors reports 5.3% passive stake in Sunesis
Subscribe for More Information
September 16, 2014
13:42 EDTSNSSSunesis volatility elevated into data from trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use